Arunis Abode Limited to Finalize Rights Issue Details in Upcoming Board Meeting
Arunis Abode Limited has scheduled a board meeting for August 20, 2025, to finalize details of its upcoming rights issue. The meeting will determine the rights issue price, payment mechanism, entitlement ratio, record date, and timing. The previously approved rights issue involves fully paid-up equity shares with a face value of Rs. 10 each, not exceeding Rs. 6,048.00 lakhs. The company has informed BSE Limited about the meeting, adhering to SEBI regulations.
11Aug 25
Arunis Abode Limited Announces Q1 Results and Interim Dividend for FY 2025-26
Arunis Abode Limited announced unaudited Q1 FY 2025-26 results, showing revenue surge to ₹1,359.65 crore from ₹19.60 crore in Q4 FY 2024-25. Profit before tax reached ₹618.39 crore, up from a loss of ₹11.13 crore. The company's new business model focusing on equipment rental and construction services drove growth. An interim dividend was declared with August 14, 2025, as the record date. The company also divested its holdings in subsidiaries and associates in April 2025.
Arunis Abode Limited issued a revised outcome of their board meeting, correcting the resignation date of CFO Mr. Ayush Dharmendrabhai Jasani to July 19, 2025. The company appointed Mrs. Preeti R Mistry as the new CFO, effective from the same date. Mrs. Mistry, a Chartered Accountant with 9 years of experience, previously worked at Grrowwide Business Advisors Private Limited. The board meeting was held on July 19, 2025, from 6:00 PM to 6:30 PM via video conferencing.
25Jul 25
Arunis Abode Limited Approves Rs. 604.8 Crore Rights Issue
Arunis Abode Limited, a Surat-based company, has approved a rights issue to raise up to Rs. 604.80 crore through fully paid-up equity shares with a face value of Rs. 10 each. The Board of Directors made this decision on July 25, 2025. A Rights Issue Committee has been formed to manage the process, including determining the issue price, rights entitlement ratio, and record date. The issue is open to eligible shareholders and is subject to regulatory approvals.